SAGE(Delisted)
Sage Therapeutics·NASDAQ
--
--(--)
Signals Analysis
Bullish signal 2
Bearish signal 0
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About SAGE
Sage Therapeutics, Inc.
A biopharmaceutical company that develops drugs to treat life-threatening, rare central nervos system disorders
215 First Street, Cambridge, Massachusetts 02142
--
Sage Therapeutics, Inc., was incorporated in Delaware on April 16, 2010. The company is a biopharmaceutical company with a mission to pioneer solutions that deliver life-changing brain health drugs so everyone can thrive. In addition to commercial products for postpartum depression, the company targets brain diseases and disorders in clinical development and early stages. As a company, the company focuses on brain health, and they are currently targeting two key central nervous system receptor systems, GABA and NMDA. The GABA receptor family is considered to be the main inhibitory neurotransmitter in the central nervous system, mediating downstream neural and bodily functions by activating GABAA receptors. The NMDA-type receptor of the glutamate receptor system is the main excitatory receptor system in the central nervous system. Dysfunction of these systems is associated with a wide range of central nervous system diseases.
Company Financials
EPS
SAGE has released its 2025 Q2 earnings. EPS was reported at -0.79, versus the expected -0.94, beating expectations. The chart below visualizes how SAGE has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
SAGE has released its 2025 Q2 earnings report, with revenue of 31.66M, reflecting a YoY change of 265.84%, and net profit of -49.65M, showing a YoY change of 51.73%. The Sankey diagram below clearly presents SAGE's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
Related Symbols
No Data
You can ask Aime
No Data
